News Summary

FluidAI Medical, a Kitchener-Waterloo-based healthtech company, has announced the acquisition of Emmetros Limited, known for its patient engagement platform SparxConnect. This acquisition is aimed at enhancing FluidAI’s AI-powered patient care technology, particularly the Stream Inara platform, which educates, monitors, and supports patients post-surgery. The deal aligns with FluidAI’s mission to improve patient outcomes and streamline recovery processes. Founded in 2014, FluidAI has been actively expanding its influence in the healthtech industry, previously acquiring intellectual property from Medsix and securing significant funding, including a $15-million Series A round in 2023. Emmetros was also founded in 2014 and is based in the Kitchener-Waterloo region. Both companies share a commitment to advancing patient care, and the acquisition is seen as a strategic move to bolster FluidAI’s offerings in the healthcare sector.